![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, February 17, 2013 6:55:16 PM
I'm a sceptic by nature, and there are few BB stocks that I'm willing to buy and hold after examining closely. While I understand the high reward to risk ratio concept, I don't want to risk blindly, or not understand the real risks and realistic reward potential.
It was the welcoming nature of this board to questions and the high quality of due diligence here that made me decide CTIX is an investment I'm willing to make. With risks I'm willing to take, and a potential reward worth holding my attention.
CTIX is a rare gem IMO;
The share structure, very high management ownership, small float, unusually favourable financing terms from Aspire Capital, research and even clinical trials being performed at little cost to Cellceutix, clinical trials active at the prestigious Harvard Cancer Center's Dana-Farber and Beth Israel Deaconess, additional great preclinical results at Beth Israel and the world renown University of Bologna using Kevetrin in combination with existing drugs that have resulted in a Phase 1b clinical trial planned this year and a Phase 2 clinical trial proposed, and that's just Kevetrin, and just a brief summary.
Add the second drug Prurisol skipping Phase 1 and going directly to Proof of Concept trials in support of advanced trials, and we have two potential blockbusters, each alone with a potential value well in excess of the current share price.
With the Aspire Capital financing, we have the prospect of CTIX seeing several clinical trials completed without the usual sort of large dilution and toxic financing that most biotech companies need when entering the clinical stage.
Truly Aspire is Investing in Cellceutix's success, on terms that make it a winner for CTIX shareholders.
And also risk. One or both drugs could fail. So high risk, with potentially very high reward.
So please, ask questions and examine Cellceutix in detail. That's the purpose of this discussion board. We all benefit from the discussion and CTIX really stands up to close scrutiny IMO.
.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM